Pramipexole
SIFROL 3.15 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 2.62 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 2.1 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 1.57 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 1.05 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 0.52 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 0.26 mg prolonged-release tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 1.1 mg tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 0.7 mg tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 0.35 mg tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 0.18 mg tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
SIFROL 0.088 mg tablets
SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... MehrProducer: Boehringer Ingelheim International GmbH
Therapeutic group: Anti-parkinson drugs
Pramipexole Teva 0.7 mg tablets
Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in... MehrProducer: Teva Pharma B.V.
Therapeutic group: Anti-parkinson drugs
Pramipexole Teva 0.18 mg tablets
Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in... MehrProducer: Teva Pharma B.V.
Therapeutic group: Anti-parkinson drugs
Pramipexole Teva 0.088 mg tablets
Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in... MehrProducer: Teva Pharma B.V.
Therapeutic group: Anti-parkinson drugs
Oprymea 1.1 mg tablets
Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... MehrProducer: Krka, d.d., Novo mesto
Therapeutic group: Anti-parkinson drugs
Oprymea 0.7 mg tablets
Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... MehrProducer: Krka, d.d., Novo mesto
Therapeutic group: Anti-parkinson drugs
Oprymea 0.35 mg tablets
Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... MehrProducer: Krka, d.d., Novo mesto
Therapeutic group: Anti-parkinson drugs
Oprymea 0.18 mg tablets
Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... MehrProducer: Krka, d.d., Novo mesto
Therapeutic group: Anti-parkinson drugs
Oprymea 0.088 mg tablets
Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... MehrProducer: Krka, d.d., Novo mesto
Therapeutic group: Anti-parkinson drugs